In the article titled "Utilization of Preventive Measures for Glucocorticoid-Induced Osteoporosis among Veterans with Inflammatory Bowel Disease" [1] , there was an error regarding the FRAX5 tool, which should be clarified as follows.
The article notes, "the WHO fracture risk predictor model (FRAX) designed to incorporate such factors in a comprehensive assessment tool has shown promising preliminary results in patients with IBD". However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2] . The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.
